|
Palo Alto, CA, January 23, 2004 — Telik, Inc. (Nasdaq:
TELK) announced that Michael M. Wick, M.D., Ph.D., chairman and
chief executive officer, will present a company update at the Piper Jaffray Health Care Conference New York City on Thursday, January
29, 2004 at 3:00 p.m. Eastern time (12:00 noon Pacific time). A
live webcast of the presentation will be accessible at Telik’s
website, www.telik.com. An archive of the webcast will be available
on the Telik website from approximately one hour after the presentation
through February 3, 2004.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases for which there is significant demand for new therapies.
The company’s most advanced drug development candidate is
TELCYTA™. Telik’s product candidates were discovered
using its proprietary drug discovery technology, TRAP, which enables
the rapid and efficient discovery of small molecule drug candidates.
Additional information is available at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
